[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_5182 

# __Delayed development and evaluation of safe and effective treatments__

## Articles mentionning the risk

* [Barcelo_environmental_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_407.md)

## Mitigations of this risk

* [Invest in research and development, streamline regulatory processes, promote collaboration and data sharing among researchers](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_7055.md)

## Name of the risk

Lack of timely access to effective therapies, prolonged impact of the pandemic, increased burden on healthcare systems

## People affected by this risk

* [Healthcare providers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_31.md)
* [Patients](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_121.md)
* [Researchers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_2.md)

## Stakeholders who can mitigate this risk

* [Government funding agencies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_413.md)
* [Pharmaceutical companies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_124.md)
* [Research institutions](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_4358.md)

## Technologies linked to the risk

* [Clinical research platforms](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_6277.md)
* [Data sharing infrastructure](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_6278.md)
* [Research funding mechanisms](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_6279.md)

## This Risk belongs to this RiskGroup

* [Public health risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_3.md)

